English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  An Enhanced Chemical Genetic Strategy to Allow Covalent Inhibition of the Fission Yeast Aurora Kinase

Koch, A., Rode, H., Rauh, D., & Hauf, S. (2009). An Enhanced Chemical Genetic Strategy to Allow Covalent Inhibition of the Fission Yeast Aurora Kinase. In 48th Annual Meeting of the American Society for Cell Biology (ASCB 2009) (pp. 294).

Item is

Basic

show hide
Genre: Meeting Abstract

Files

show Files

Locators

show
hide
Description:
-
OA-Status:
Not specified

Creators

show
hide
 Creators:
Koch, A1, Author                 
Rode, HB, Author
Rauh, D, Author
Hauf, S1, Author                 
Affiliations:
1Hauf Group, Friedrich Miescher Laboratory, Max Planck Society, ou_3377924              

Content

show
hide
Free keywords: -
 Abstract: Analog-sensitive (as) kinases differ from their natural counterparts by a single amino-acid change in the ATP binding pocket. This so called gatekeeper mutation enlarges the ATP binding site and makes the kinase susceptible to specific inhibitors that typically do not target unmodified kinases. The high conservation of the kinase domain allows identification of the gatekeeper residue in most kinases, and as-kinases have been successfully created in organisms from yeast to human. Here we report on the introduction of a second mutation to successfully target a serine/threonine as-kinase with covalent inhibitors. Through structure-based design we identified a residue close to the ATP binding pocket, whose mutation to cysteine creates an anchor point for irreversible kinase inhibitors. We demonstrate the feasibility of this approach for an as-version of the conserved fission yeast (Schizosaccharomyces pombe) Aurora kinase Ark1. Aurora is essential for the proper execution of mitosis and small-molecule inhibitors selective for Aurora have been crucial to decipher its role during the cell cycle. We employed structure-guided chemical synthesis of a focused library of 4-anilino-quinazolines equipped with diverse reactive groups and show that some of the compounds specifically inhibit Ark1 carrying the gatekeeper mutation as well as the engineered cysteine, but not the kinase with only one of these mutations.

Details

show
hide
Language(s):
 Dates: 2009-12
 Publication Status: Published online
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: -
 Degree: -

Event

show
hide
Title: 48th Annual Meeting of the American Society for Cell Biology (ASCB 2009)
Place of Event: San Diego, CA, USA
Start-/End Date: 2009-12-05 - 2009-12-09

Legal Case

show

Project information

show

Source 1

show
hide
Title: 48th Annual Meeting of the American Society for Cell Biology (ASCB 2009)
Source Genre: Proceedings
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: - Sequence Number: 608/B555 Start / End Page: 294 Identifier: -